Table 1:
Consequence of the genetic manipulation of ISR components in mice
Member | Model | Development | Phenotypes | Ref. |
---|---|---|---|---|
ATF4 | CREB−/− | Retarded | Defective lens development, and microphthalmia Anemia Dwarfisms and severe skeletal abnormalities |
30, 59, 174, 176, 177 |
CREB+/− | Normal | No specific phenotype | ||
CREB−/− and P53−/−double KO | -- | Normal eye morphology, lower number of lens fibers | ||
GCN2 | GCN2−/− | Normal | Developmental delay occurred if being fed with leucine deficit diet | 178 |
HRI | HRI−/− |
Normal | Macrocytosis and hyperchromia | 51 |
PKR | Pkr−/− | Normal | No specific phenotype | 179 |
PERK | Perk−/− | Retarded | Impaired insulin secretion and hyperglycemia; Growth retardation and abnormal bone development |
180–183 |
Perk−/− | -- | Acute diabetes | 194 | |
Perk loxP/loxP & CamkIIα-Cre | -- | Behavior change | 184 | |
GADD34 | GADD34−/− | Normal | No signs of disease or abnormal phenotypes at least the first 12 months of life | 145 |
CReP | Ppp1r15b−/− | Retarded | Half size, pale skin, impaired erythropoiesis, fail to survive in postnatal day 1 | 186 |
Ppp1r15b+/− | Normal | No specific phenotype | ||
EIF2α | Homozygous non-phosphorylatable KI (S51A) | Lethal | Severe hypoglycemia. Lethal within 24 hours of birth. |
188 |
Heterozygous non-phosphorylatable KI (S51A) | Normal | Glucose intolerance, increased weight gain if been fed with high fat diet, pancreatic β-cell failure. | 189 | |
Conditional β-cell specific KO | -- | Decreased insulin secretion, type 2 DM | 190 | |
CHOP | CHOP−/− | Normal | Reduced performance in memory-related behaviors | 192 |
KO: knock out; KI: knock in